MOESM3 of Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial
Aram Yang
Jin-Ho Choi
Young Sohn
Yunae Eom
Jiyoon Lee
Han-Wook Yoo
Dong-Kyu Jin
10.6084/m9.figshare.9809432.v1
https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Effects_of_recombinant_human_growth_hormone_treatment_on_growth_body_composition_and_safety_in_infants_or_toddlers_with_Prader-Willi_syndrome_a_randomized_active-controlled_trial/9809432
Additional file 3: Table S3. Analysis of covariance on the change from baseline of LBM (g) at week 52 (Efficacy set).
2019-09-12 04:11:14
Prader-Willi syndrome
Growth hormone therapy
Body composition
Psychomotor development
Infants and toddlers